Functional evidence covering tau aggregation, transcriptional impact of ADIPOQ knockout for cardiomyoblasts, and the quantitative assessment of cognition and cardiac muscle structures persistently indicate the pleiotropy of the ADIPOQ variant (c.268G>A) in CD and AD/D. The gene discussed is MAPT; the disease is Alzheimer disease.